Vedolizumab

Abstract

No therapeutic response: case reportIn a retrospective chart review, including 90 patients with inflammatory bowel disease, conducted between June 2014 and December 2018, a patient [age and sex not stated] was described, who exhibited no therapeutic response to vedolizumab while being treated for crohn's disease. The patient received vedolizumab during maintenance phase [dosage and route not stated]. However, the patient exhibited no response to vedolizumab during maintenance phase.